Member Info for Allenby

I think Olav mentioned that Forsun was going to fund a number of staff salaries but did not mention how many. Not sure this will require a RNS.

Hi Leem ,Things are not looking good. Our major shareholder Obotritia has sold 10% of its holding that is 0.58m shares on Friday Also the non- executive director Barbara Staehelin must be regretting her purchase of 43000 shares in Oct 2021 at 115p per share now worth 30p. a share. You must wonder if the Directors cannot get the purchasing right what chance do the rest of us have.

May be a dead cat bounce

Shareholders here must be on there guard not to give the BOB authorization to act without final agreement from the shareholders. The BOD must put any takeover deal and any disposal of assets such as Patents, to a vote by the shareholders of the company before it is ratified. To give them permission to act without the safeguard is dangerous.
I know from experience giving the BOD this authorization to act without final shareholders sanction can be painful.
I was a shareholder in Flybe, the board at a special EGM voted to make decisions without needing a shareholders vote.
They sold the assets of the company the agreed to a takeover from Richard Branson which gave the shareholders 1 p a share
then he gave the then BOD a contract of employment.
I think this has happened to other AIM companies ,we must be on our guard here.

We are almost in a position that we could cash up and give all the shareholders the cash in the bank and show a profit on todays price.

I think our Director Barbara Staehalin must be regretting her purchase of 43000 shares on October 21st 2021 for 115p she is now well over £15000 down now ,like many here hindsight is a wonderful thing. But I do not see any other directors even at the current price purchasing any more shares not even the new recruit Dr Randolph Corteling.

It will be interesting to see after the 3rd March when Randolph Corteling joins ReNeuron if he will purchase some shares and have some skin the the game. He does not appear to have any shares at present.

J Henry, I have Schroders selling 3.22 m shares on 30th Sep 2021 and still have 3.61% or 2.06m shares. However Invus purchased 1.73m shares on 22 nd Sep 2021 and now own 3.04% The SP is having a much better day today some good news maybe on the way.

With news that over 30 ships have covid is there any news on our ships?

Hi Chester I think you are correct it was 1 for 100 so Olav would hold only 3, 227 at that time not 32,277 shares as stated. He must of increased his stake since then to 50,201 shares as listed at the end of Sept 2021.
Does anyone know why the company did not issue a RNS when Schoder sold 3,219,514 shares at the end of September 2021 taking their holdings from 9.284% to 1.18% now.?

Yes I forgot about the one for ten consolidation thanks Phil.

Olav Hellebo was appointed to CEO in Sep 2014 he was listed as having 322,778 shares in Jan 2015 , He is now listed as having only 50,201 shares so must have sold down to this figure which now equates to 0.09% of the company. So unlike us LTS holders who over the years have tried to average down buy buying more he has just sold his allocation. This would help explain why he is not very interested in what happens to the share price.

Today the 14th Dec a upgrade to buy from Zacks Investments Research for ReNeuron

Hi Leem1 you did well to get out when you did, I think I may have an idea why the price is still falling, Schroder sold 3.22mill shares in September 2021 , taking their share of the company down from 9.27% to 3.61% (I do not recall a RSM from the company on this though) ,It would take many weeks for the brokers to dispose of the stock given the low level of dealing. It is now December and hopefully they have found a home for the 3.11 million shares.
At the 10 Dec 2021, this is the state of the Major Share holders Obotritia 10.72%, Griffiths Richard 7.97%, Octopus 5.87% Rosetta 5.64% ,Arix capt5.26%, Schoder 3.61%, The Invus Group 3.04%, Evans Sir Christopher 2.95%, Evans Mark 1.56%, Spreadex 1.17%, The only purchases from the above from September 2021 are from Invus group why bought 1.73 mill shares and Aberdeen Asset who bought 0.59 mill shares. None of the Major share holders have sold except Schroder.
With over 3.22 million share being offloaded the there will always be a downward pressure on the SP.
As a LTSH I hope next year will bring a rise in the SP and no more large sales from the big players.

I agree , this was the pattern before the last placing.

Nickolas Peter I to have eternal hope but even after Zacks increased the rating on Reneuron from hold to buy on the 7th Dec the price is still going down, And I am not sure how much more it will go. I think Leem1 had lost patience and got out but as a long term holder I will give a few more months.

Apart from A Ferguson and Tom Reynolds the rest of the board do not seam to hold any shares. Not a good sign. They are Doug Rycroft ,John Alpine, Muir Miller & Donald Nicolson

As a background to the Q & A session I would like to log the major shareholders,
GP Jersey ltd 8.6%, Fitzpatrick Jon 3.45% Fitzpatrick Alaster Muir 3.21% Spreadex Ltd 1.55% Maccallum James Gibson0.88% Reynolds Thomas 0.32%
I think the above will have a big say on any deal being done

Three late buys for 50,000 shares each at just over 115p looks good for Monday opening.

You are right PC, The American Banking News today 19 th Nov have listed ReNeuron as having crossed below the 200 day moving average on Thursday the 18th Nov. They comment that the 200 day moving average was £110.6 and ReNeuron traded as low as £99 and closed at £104 with a volume of 259,022 shares,
This may explain the lack of any US buying today but they may start buying when their market opens later.